Yann Mazabraud - 14 Apr 2024 Form 4 Insider Report for RHYTHM PHARMACEUTICALS, INC. (RYTM)

Role
EVP, Head of International
Signature
/s/ Hunter Smith, attorney-in-fact for Yann Mazabraud
Issuer symbol
RYTM
Transactions as of
14 Apr 2024
Net transactions value
$0
Form type
4
Filing time
16 Apr 2024, 20:11:12 UTC
Previous filing
19 Mar 2024
Next filing
19 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RYTM Common Stock Options Exercise -10,375 -23% 34,870 14 Apr 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RYTM Restricted Stock Units Options Exercise $0 -10,375 -25% $0.000000 31,125 14 Apr 2024 Common Stock 10,375 Direct F1, F2
transaction RYTM Restricted Stock Units Disposed to Issuer $0 -2,031 -100% $0.000000* 0 15 Apr 2024 Common Stock 2,031 Direct F1, F3, F4
transaction RYTM Restricted Stock Units Disposed to Issuer $0 -6,874 -100% $0.000000* 0 15 Apr 2024 Common Stock 6,874 Direct F1, F5, F6
transaction RYTM Restricted Stock Units Award $0 +8,905 $0.000000 8,905 15 Apr 2024 Common Stock 8,905 Direct F1, F7
transaction RYTM Restricted Stock Units Award $0 +10,000 $0.000000 10,000 15 Apr 2024 Common Stock 10,000 Direct F1, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
F2 The restricted stock units vest or have vested as to 25% of the total shares on each of April 14, 2024, April 14, 2025, April 14, 2026 and April 14, 2027. The restricted stock units have no expiration date.
F3 The restricted stock units were rescinded and cancelled by mutual agreement of the reporting person and Issuer. The reporting person received French-qualified restricted stock units on April 15, 2024 as consideration for the recission and cancellation of the unvested portion of the restricted stock previously received on February 11, 2021.
F4 The restricted stock units vest or have vested as to 25% of the total shares on each of February 11, 2022, February 11, 2023, February 11, 2024 and February 11, 2025. The restricted stock units have no expiration date.
F5 The restricted stock units were rescinded and cancelled by mutual agreement of the reporting person and Issuer. The reporting person received French-qualified restricted stock units on April 15, 2024 as consideration for the recission and cancellation of the unvested portion of the restricted stock previously received on February 9, 2022.
F6 The restricted stock units vest or have vested as to 25% of the total shares on each of February 9, 2023, February 9, 2024, February 9, 2025 and February 9, 2026. The restricted stock units have no expiration date.
F7 The restricted stock units vest in full on April 15, 2025. The restricted stock units have no expiration date.
F8 The restricted stock units vest or have vested as to 25% of the total shares on each of April 15, 2025, April 15, 2026, April 15, 2027 and April 15, 2028. The restricted stock units have no expiration date.